Cost-effectiveness of remdesivir plus usual care versus usual care alone for hospitalized patients with COVID-19: an economic evaluation as part of the Canadian Treatments for COVID-19 (CATCO) randomized clinical trial-Reference-Cited by-同舟云学术

Cost-effectiveness of remdesivir plus usual care versus usual care alone for hospitalized patients with COVID-19: an economic evaluation as part of the Canadian Treatments for COVID-19 (CATCO) randomized clinical trial

Published:2022-07 Issue:3 Volume:10 Page:E807-E817
ISSN:2291-0026
Container-title:CMAJ Open
language:en
Short-container-title:cmajo

Author:

Lau Vincent I.,Fowler Robert,Pinto Ruxandra,Tremblay Alain,Borgia Sergio,Carrier François M.,Cheng Matthew P.,Conly John,Costiniuk Cecilia T.,Daley Peter,Duan Erick,Durand Madeleine,Fontela Patricia S.,Farjou George,Fralick Mike,Geagea Anna,Grant Jennifer,Keynan Yoav,Khwaja Kosar,Lee Nelson,Lee Todd C.,Lim Rachel,O’Neil Conar R.,Papenburg Jesse,Semret Makeda,Silverman Michael,Sligl Wendy,Somayaji Ranjani,Tan Darrell H.S.,Tsang Jennifer L.Y.,Weatherald Jason,Yansouni Cedric Philippe,Zarychanski Ryan,Murthy Srinivas

Publisher

CMA Impact Inc.

Subject

General Medicine

Reference31 articles.

1. A living WHO guideline on drugs for covid-19

2. Remdesivir for severe covid-19: a clinical practice guideline

3. (2020) COVID-19 Treatment Guidelines Panel Coronavirus disease 2019 (COVID-19) treatment guidelines (National Institute of Health, Bethesda (MD)), pp 1–224.

4. Remdesivir for the Treatment of Covid-19 — Final Report

5. Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2 viral load is linked to remdesivir efficacy in severe Covid-19 admitted to intensive care;Scientific Reports;2024-09-06

2. Lessons Learned from Model-based Economic Evaluations of COVID-19 Drug Treatments Under Pandemic Circumstances: Results from a Systematic Review;PharmacoEconomics;2024-05-10

3. COVID -19: On the threshold of the fifth year. The situation in Spain;Revista Española de Quimioterapia;2023-11-27

4. Diagnostics and treatments of COVID-19: two-year update to a living systematic review of economic evaluations;Frontiers in Pharmacology;2023-11-16

5. Remdesivir: A Review in COVID-19;Drugs;2023-08-17